Daily aspirin reduces risk of ovarian cancer, regardless of genetics

Published Date: 08 Mar 2023

New findings show that frequent aspirin use provides protection against ovarian cancer, regardless of a person's genetic risk.

Read Full News

Latest News

Male Factors, Female Burden: Rethinking Infertility Care

Delayed childbearing has increased pregnancies after age 35, and while assisted reproduction expands options, older parenthood raises clinical, social, and policy challenges.

Endometriosis: Recent Advances May Speed Time to Diagnosis

A new guideline from ACOG urges faster, nonsurgical diagnosis of endometriosis; research is identifying biomarkers that help simplify the process in the future.

Can Better Screening Prevent Maternal VTE Deaths?

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

Bed Rest Won’t Stop Preterm Birth in Women With Short Cervix

Activity restriction does not appear to lower the risk for preterm birth in pregnant women with a short cervix; it may even have the opposite effect.

Infodemic Threatens Women’s Clinical Decisions

1 in 5 French women says misinformation has already influenced their health decisions; nearly 40% of those women reported harm, including ineffective treatment or loss of trust.

Social Fund Can Be Used to Allow Access to Safe Abortions, EU

Member states may use an existing EU social fund to terminate pregnancies free of charge for women visiting ⁠from EU nations that restrict access to safe abortions.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Latest News

Delayed childbearing has increased pregnancies after age 35, and while assisted reproduction expands options, older parenthood raises clinical, social, and policy challenges.

A new guideline from ACOG urges faster, nonsurgical diagnosis of endometriosis; research is identifying biomarkers that help simplify the process in the future.

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

Activity restriction does not appear to lower the risk for preterm birth in pregnant women with a short cervix; it may even have the opposite effect.

1 in 5 French women says misinformation has already influenced their health decisions; nearly 40% of those women reported harm, including ineffective treatment or loss of trust.

Member states may use an existing EU social fund to terminate pregnancies free of charge for women visiting ⁠from EU nations that restrict access to safe abortions.

News All Time

Common cesarean closure method linked to long-term complications, experts suggest change

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

From post-partum depression to relationship woes: The importance of mental health after giving birth

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

Pain during a C-section? New study challenges fears about general anesthesia

Regional anesthesia—typically with a spinal or epidural block—has long been favored for cesarean births due in part to concerns about the effects that general anesthesia may have on newborns during labor and delivery. ...

Researchers call for greater clarity around prenatal screening forms

A new Australian study has found that forms used for one of the most common genetic screening tests in pregnancy—costing prospective parents up to $550—are often confusing and inconsistent, blurring the lines between ...

Majority of Georgia women surveyed would support abortion at 14 weeks, beyond the current legal limit

Among a cross-sectional group of women of reproductive age in Georgia, 76% supported the legality of abortion access at six weeks and 60% supported it at 14 weeks, according to a new study published in the open-access journal ...

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy often fails even when tumors express the hormone receptor that should make them responsive. The study ...

Self-guided hypnosis can significantly reduce menopausal hot flashes

Can a simple daily audio hypnosis session help women find relief from one of menopause's most disruptive symptoms—hot flashes—without medication? A new clinical trial led by Baylor University's Gary R. Elkins, Ph.D., ...

Husbands' self-esteem linked to lower risk of preterm birth in partners

A husband's optimism and confidence may play a crucial, if often unseen, role in helping babies arrive healthy and on time.

More women sought permanent contraception after Supreme Court Dobbs decision

In June 2022, the U.S. Supreme Court's decision in Dobbs v. Jackson Women's Health Organization ended the federal constitutional right to abortion and returned authority to individual states to regulate abortion. A new study ...

Sexual dysfunction in women at midlife explored by largest study of its kind

Almost 50% of women in midlife surveyed in a Monash University-led study had poor sexual well-being, including a doubling of the likelihood of desire and arousal dysfunction in early perimenopausal women from premenopause.

After Dobbs, Illinois abortion clinics saw surge in out-of-state patients

Following the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, two large Illinois abortion providers saw a 35% increase in abortions, driven by out-of-state patients who lived where abortion care ...

Study shows good British Columbia abortion pill access, but gaps remain

Most pharmacies in British Columbia can provide the abortion pill mifepristone within days, but uneven access still leaves some women facing barriers to this time-sensitive medication, according to new research.

New study shows long-term effectiveness of HPV vaccine

A new study has confirmed that the human papillomavirus (HPV) vaccine provides strong and sustained protection against cervical disease that can develop into cancer.

Exercise reduces risk of common postpartum pelvic floor problems

Targeted pelvic floor muscle training in the first year postpartum significantly reduces the risk of two common pelvic floor disorders, according to a study that rewrites the longstanding narrative that these disorders are ...

Problems with regulating emotions during pregnancy may help predict perinatal depression

Around 1 in 5 mothers experience perinatal depression. This condition involves depressive episodes during pregnancy or just after birth—often with lasting effects on both mother and child.

Sugar–protein interactions, critical for placenta during early pregnancy, shed light on common complications

During the first weeks of pregnancy, the developing placenta in a mother's womb undergoes a dramatic change. Individual cells merge, forming a continuous barrier that will spend the next nine months ferrying oxygen and nutrients ...

Recommended News For You

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

a brand-new generic therapy for different types of cancer.

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.

Severe obesity associated with reduced prevalence of recommended cancer screenings

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

New study elucidates obesity's role in fueling breast cancer progression

Year in Review: Chronic Lymphocytic Leukemia

Recommended Articles For You

Exploring the Benefits of Endari: How This Natural Remedy Can Help You Live a Healthier Life 

Debunking Myths About Systemic Mastocytosis: Separating Fact from Fiction  

Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition 

Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise.

2.

Smart exercise planning could boost recovery for people with cancer

3.

Updates from the 2022 WHO classification of kidney epithelial tumors

4.

ALK-positive lung cancer trial results show unprecedented progression-free survival.

5.

After two years, a significant left nasal obstruction was finally diagnosed.

1.

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction

2.

Gut microbiota in curing cancer

3.

Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients

4.

Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection

5.

Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

4.

Navigating the Complexities of Ph Negative ALL - Part I

5.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot